• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不动杆菌感染的临床与病理生理学概述:一个世纪的挑战

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

作者信息

Wong Darren, Nielsen Travis B, Bonomo Robert A, Pantapalangkoor Paul, Luna Brian, Spellberg Brad

机构信息

Division of Infectious Diseases, Keck School of Medicine of the University of Southern California (USC), Los Angeles, California, USA

Division of Infectious Diseases, Keck School of Medicine of the University of Southern California (USC), Los Angeles, California, USA.

出版信息

Clin Microbiol Rev. 2017 Jan;30(1):409-447. doi: 10.1128/CMR.00058-16.

DOI:10.1128/CMR.00058-16
PMID:27974412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5217799/
Abstract

Acinetobacter is a complex genus, and historically, there has been confusion about the existence of multiple species. The species commonly cause nosocomial infections, predominantly aspiration pneumonia and catheter-associated bacteremia, but can also cause soft tissue and urinary tract infections. Community-acquired infections by Acinetobacter spp. are increasingly reported. Transmission of Acinetobacter and subsequent disease is facilitated by the organism's environmental tenacity, resistance to desiccation, and evasion of host immunity. The virulence properties demonstrated by Acinetobacter spp. primarily stem from evasion of rapid clearance by the innate immune system, effectively enabling high bacterial density that triggers lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4)-mediated sepsis. Capsular polysaccharide is a critical virulence factor that enables immune evasion, while LPS triggers septic shock. However, the primary driver of clinical outcome is antibiotic resistance. Administration of initially effective therapy is key to improving survival, reducing 30-day mortality threefold. Regrettably, due to the high frequency of this organism having an extreme drug resistance (XDR) phenotype, early initiation of effective therapy is a major clinical challenge. Given its high rate of antibiotic resistance and abysmal outcomes (up to 70% mortality rate from infections caused by XDR strains in some case series), new preventative and therapeutic options for Acinetobacter spp. are desperately needed.

摘要

不动杆菌是一个复杂的菌属,在历史上,对于多种菌种的存在一直存在混淆。这些菌种通常引起医院感染,主要是吸入性肺炎和导管相关菌血症,但也可引起软组织和尿路感染。越来越多的报告称不动杆菌属可引起社区获得性感染。不动杆菌的传播及其后续疾病的发生得益于该菌在环境中的顽强生存能力、对干燥的抵抗力以及对宿主免疫的逃避。不动杆菌属所表现出的毒力特性主要源于逃避先天免疫系统的快速清除,从而有效地实现高细菌密度,进而引发脂多糖(LPS)-Toll样受体4(TLR4)介导的脓毒症。荚膜多糖是一种关键的毒力因子,可实现免疫逃避,而LPS则引发感染性休克。然而,临床结局的主要驱动因素是抗生素耐药性。给予最初有效的治疗是提高生存率的关键,可将30天死亡率降低三倍。遗憾的是,由于这种细菌具有极高耐药性(XDR)表型的频率很高,尽早开始有效治疗是一项重大的临床挑战。鉴于其高抗生素耐药率和糟糕的预后(在某些病例系列中,XDR菌株引起的感染死亡率高达70%),迫切需要针对不动杆菌属的新的预防和治疗方案。

相似文献

1
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.不动杆菌感染的临床与病理生理学概述:一个世纪的挑战
Clin Microbiol Rev. 2017 Jan;30(1):409-447. doi: 10.1128/CMR.00058-16.
2
[Acinetobacter: microbiological, pathogenetic and resistant properties].[不动杆菌:微生物学、发病机制及耐药特性]
Vestn Ross Akad Med Nauk. 2014(9-10):39-50. doi: 10.15690/vramn.v69i9-10.1130.
3
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.由鲍曼不动杆菌引起的社区获得性血流感染:一项匹配病例对照研究。
J Microbiol Immunol Infect. 2018 Oct;51(5):629-635. doi: 10.1016/j.jmii.2017.02.004. Epub 2017 Jun 29.
4
Acinetobacter baumannii: an emerging multidrug-resistant threat.鲍曼不动杆菌:一种新出现的多重耐药威胁。
Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309.
5
Treatment of Acinetobacter infections.治疗不动杆菌感染。
Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350.
6
Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.多重耐药和广泛耐药鲍曼不动杆菌医院感染与高死亡率相关:儿科重症监护病房的回顾性研究。
BMC Infect Dis. 2020 Aug 12;20(1):597. doi: 10.1186/s12879-020-05321-y.
7
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.社区获得性皮氏不动杆菌引起空洞性肺炎的首例报告、毒力研究及发病机制与治疗概述
BMC Infect Dis. 2017 Jul 6;17(1):477. doi: 10.1186/s12879-017-2589-0.
8
Multidrug-resistant Acinetobacter: a threat to the antibiotic era.多重耐药鲍曼不动杆菌:对抗生素时代的威胁。
Intern Med J. 2006 Aug;36(8):479-82. doi: 10.1111/j.1445-5994.2006.01130.x.
9
Emergence of antimicrobial resistance among Acinetobacter species: a global threat.不动杆菌属细菌中抗菌药物耐药性的出现:一种全球威胁。
Curr Opin Crit Care. 2016 Oct;22(5):491-9. doi: 10.1097/MCC.0000000000000337.
10
Antimicrobial Resistance in spp. and spp.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的耐药性
Microbiol Spectr. 2018 Jun;6(3). doi: 10.1128/microbiolspec.ARBA-0007-2017.

引用本文的文献

1
An activator regulates the DNA damage response and anti-phage defense networks in Moraxellaceae.一种激活剂调节莫拉菌科中的DNA损伤反应和抗噬菌体防御网络。
Nucleic Acids Res. 2025 Aug 27;53(16). doi: 10.1093/nar/gkaf828.
2
Eravacycline Treatment for Carbapenem-Resistant in Lung Transplant Recipients: A Real-World Retrospective Study.依拉环素治疗肺移植受者耐碳青霉烯菌感染:一项真实世界回顾性研究。
Infect Drug Resist. 2025 Aug 16;18:4125-4139. doi: 10.2147/IDR.S529016. eCollection 2025.
3
Virulence factors are preserved within carbapenem-resistant clades.毒力因子在耐碳青霉烯类进化枝中得以保留。
Virulence. 2025 Dec;16(1):2542489. doi: 10.1080/21505594.2025.2542489. Epub 2025 Aug 24.
4
Integrated analysis of O/K-antigen biosynthesis diversity and molecular serotyping scheme development of Vibrio alginolyticus.溶藻弧菌O/K抗原生物合成多样性的综合分析及分子血清分型方案的制定
BMC Microbiol. 2025 Aug 23;25(1):537. doi: 10.1186/s12866-025-04216-9.
5
Phylogenomic analysis of OXA-23-positive and genetic context of rare NDM-1-producing carbapenem-resistant isolates in a teaching hospital in China.中国一家教学医院中OXA-23阳性菌株的系统基因组分析及罕见产NDM-1碳青霉烯耐药菌株的遗传背景
Front Microbiol. 2025 Aug 6;16:1575257. doi: 10.3389/fmicb.2025.1575257. eCollection 2025.
6
A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections.一种用于研究长期毒力因子、抗生素治疗和混合感染的慢性鲍曼不动杆菌肺炎模型。
Nat Commun. 2025 Aug 15;16(1):7617. doi: 10.1038/s41467-025-62655-4.
7
Characterization and Complete Genomic Analysis of a Novel Bacteriophage BUCT775 for and Its Elimination Efficiency in the Environment.新型噬菌体BUCT775的特性及其在环境中的消除效率的全基因组分析
Int J Mol Sci. 2025 Jul 28;26(15):7279. doi: 10.3390/ijms26157279.
8
Genomic and phenotypic characterization of six multidrug-resistant Acinetobacter pittii isolates.六株多重耐药皮特不动杆菌分离株的基因组和表型特征分析
Sci Rep. 2025 Aug 12;15(1):29577. doi: 10.1038/s41598-025-15848-2.
9
DNA uptake and twitching motility are controlled by the small RNA Arp through repression of pilin translation in .DNA摄取和颤动运动性由小RNA Arp通过抑制菌毛蛋白翻译来控制。
bioRxiv. 2025 Jul 19:2025.07.19.665661. doi: 10.1101/2025.07.19.665661.
10
Resistance and heteroresistance as a consequence of colistin therapy during murine pneumonia.在小鼠肺炎期间,黏菌素治疗导致的耐药性和异质性耐药。
bioRxiv. 2025 Jul 24:2025.07.24.666669. doi: 10.1101/2025.07.24.666669.

本文引用的文献

1
Surveillance for and susceptibility of Acinetobacter baumannii in a large hospital and burn center in Shanghai, China, 2007-2013.2007 - 2013年中国上海一家大型医院及烧伤中心鲍曼不动杆菌的监测与药敏情况
Am J Infect Control. 2016 Dec 1;44(12):1718-1719. doi: 10.1016/j.ajic.2016.06.014. Epub 2016 Aug 17.
2
Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.重症患者广泛耐药鲍曼不动杆菌呼吸机相关性肺炎的临床流行病学、治疗和预后因素。
Int J Antimicrob Agents. 2016 Nov;48(5):492-497. doi: 10.1016/j.ijantimicag.2016.07.007. Epub 2016 Aug 12.
3
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014.2008 - 2014年印度一家大型私立实验室网络对血培养分离出的主要细菌病原体的抗生素耐药性趋势
Int J Infect Dis. 2016 Sep;50:75-82. doi: 10.1016/j.ijid.2016.08.002. Epub 2016 Aug 10.
4
Structure of repeating unit of the capsular polysaccharide from Acinetobacter baumannii D78 and assignment of the K4 gene cluster.鲍曼不动杆菌D78荚膜多糖重复单元的结构及K4基因簇的定位
Carbohydr Res. 2016 Nov 3;434:12-17. doi: 10.1016/j.carres.2016.07.016. Epub 2016 Jul 15.
5
Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.不动杆菌属与重症监护病房菌血症患者的较高死亡率相关:一项生存分析。
BMC Infect Dis. 2016 Aug 9;16:386. doi: 10.1186/s12879-016-1695-8.
6
Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis.鲍曼不动杆菌苯乙酸代谢通过对中性粒细胞趋化性的直接影响来影响感染结果。
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9599-604. doi: 10.1073/pnas.1523116113. Epub 2016 Aug 9.
7
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.野生环境噬菌体的个性化治疗组合拯救了受鲍曼不动杆菌伤口感染的小鼠。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5806-16. doi: 10.1128/AAC.02877-15. Print 2016 Oct.
8
Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.多药耐药鲍曼不动杆菌肺炎患者接受黏菌素治疗的死亡预测因素。
Int J Antimicrob Agents. 2016 Aug;48(2):175-80. doi: 10.1016/j.ijantimicag.2016.05.011. Epub 2016 Jul 5.
9
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis.鲍曼不动杆菌肺炎和脓毒症中的多重耐药性、不适当的经验性治疗及医院死亡率
Crit Care. 2016 Jul 11;20(1):221. doi: 10.1186/s13054-016-1392-4.
10
IncM Plasmid R1215 Is the Source of Chromosomally Located Regions Containing Multiple Antibiotic Resistance Genes in the Globally Disseminated Acinetobacter baumannii GC1 and GC2 Clones.IncM质粒R1215是全球传播的鲍曼不动杆菌GC1和GC2克隆中包含多个抗生素抗性基因的染色体定位区域的来源。
mSphere. 2016 Jun 8;1(3). doi: 10.1128/mSphere.00117-16. eCollection 2016 May-Jun.